Page last updated: 2024-12-07
safrole oxide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
safrole oxide: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 101123 |
CHEMBL ID | 199838 |
SCHEMBL ID | 1262235 |
MeSH ID | M0053692 |
Synonyms (38)
Synonym |
---|
safrole epoxide |
2',3'-epoxysafrol [french] |
benzene, 4-(2,3-epoxypropyl)-1,2-(methylenedioxy)- |
brn 0163628 |
ai3-33068 |
1,3-benzodioxole, 5-(2,3-epoxypropyl)- |
safrole-2',3'-oxide |
safrole oxide |
2',3'-epoxysafrole |
nsc 402793 |
5-(oxiranylmethyl)-1,3-benzodioxole |
1,3-benzodioxole, 5-(oxiranylmethyl)- |
nsc-402793 |
nsc402793 |
7470-44-2 |
1, 5-(oxiranylmethyl)- |
5-(oxiran-2-ylmethyl)-1,3-benzodioxole |
CHEMBL199838 |
AKOS006273156 |
safrole 2',3'-oxide |
1-(3',4'-methylenedioxyphenyl)-2,3-epoxypropane |
1x8lby54mv , |
unii-1x8lby54mv |
2',3'-epoxysafrol |
5-19-09-00191 (beilstein handbook reference) |
KZYXVVGEWCXONF-UHFFFAOYSA-N |
SCHEMBL1262235 |
(+/-)-safrole oxide |
2-piperonyloxirane |
1,3-benzodioxole, 5-(2-oxiranylmethyl)- |
5-glycidyl-1,3-benzodioxole |
5-(oxiran-2-ylmethyl)benzo[d][1,3]dioxole |
Q27253030 |
STARBLD0003132 |
EN300-1996371 |
5-[(oxiran-2-yl)methyl]-1,3-dioxaindane |
DTXSID401032715 |
5-(2-oxiranylmethyl)-1,3-benzodioxole |
Research Excerpts
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (10)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID307214 | Induction of apoptosis in neural stem cells co-cultured with vascular endothelial cells assessed as neurites degeneration at 70 ug/mL after 10 hrs | 2007 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11 | Safrole oxide is a useful tool for investigating the effect of apoptosis in vascular endothelial cells on neural stem cell survival and differentiation in vitro. |
AID258400 | Effect on caspase 3 activation to initiate apoptosis in A549 human lung cancer cell line | 2006 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 16, Issue:1 | Safrole oxide induces apoptosis by activating caspase-3, -8, and -9 in A549 human lung cancer cells. |
AID307218 | Induction of apoptosis in neural stem cells co-cultured with vascular endothelial cells assessed as DNA fragmentation at 70 ug/mL after 10 hrs | 2007 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11 | Safrole oxide is a useful tool for investigating the effect of apoptosis in vascular endothelial cells on neural stem cell survival and differentiation in vitro. |
AID307213 | Induction of apoptosis in neural stem cells assessed as cell viability at 10 to 100 ug/mL by MTT assay | 2007 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11 | Safrole oxide is a useful tool for investigating the effect of apoptosis in vascular endothelial cells on neural stem cell survival and differentiation in vitro. |
AID258402 | Effect on caspase 9 activation to initiate apoptosis in A549 human lung cancer cell line | 2006 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 16, Issue:1 | Safrole oxide induces apoptosis by activating caspase-3, -8, and -9 in A549 human lung cancer cells. |
AID307215 | Induction of apoptosis in neural stem cells co-cultured with vascular endothelial cells assessed as inhibition of cell differentiation at 70 ug/mL after 10 hrs | 2007 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11 | Safrole oxide is a useful tool for investigating the effect of apoptosis in vascular endothelial cells on neural stem cell survival and differentiation in vitro. |
AID307217 | Induction of apoptosis in neural stem cells co-cultured with vascular endothelial cells assessed as nuclear condensation at 70 ug/mL after 10 hrs | 2007 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11 | Safrole oxide is a useful tool for investigating the effect of apoptosis in vascular endothelial cells on neural stem cell survival and differentiation in vitro. |
AID307219 | Increase in apoptosis rate in neural stem cells co-cultured with vascular endothelial cells assessed as cell survival at 70 ug/mL after 10 hrs | 2007 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11 | Safrole oxide is a useful tool for investigating the effect of apoptosis in vascular endothelial cells on neural stem cell survival and differentiation in vitro. |
AID307216 | Induction of necrosis in neural stem cells co-cultured with vascular endothelial cells assessed as LDH release at 70 ug/mL after 10 hrs relative to control | 2007 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11 | Safrole oxide is a useful tool for investigating the effect of apoptosis in vascular endothelial cells on neural stem cell survival and differentiation in vitro. |
AID258401 | Effect on caspase 8 activation to initiate apoptosis in A549 human lung cancer cell line | 2006 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 16, Issue:1 | Safrole oxide induces apoptosis by activating caspase-3, -8, and -9 in A549 human lung cancer cells. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (25)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (8.00) | 18.7374 |
1990's | 2 (8.00) | 18.2507 |
2000's | 11 (44.00) | 29.6817 |
2010's | 6 (24.00) | 24.3611 |
2020's | 4 (16.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.84
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.84) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (4.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 24 (96.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |